Scalpel Versus Diathermy for Transverse Abdominal Incision in First Elective Caesarean Section

Sponsor
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05905861
Collaborator
(none)
84
1
2
17.1
4.9

Study Details

Study Description

Brief Summary

The objective of this study will be to compare two methods of skin incisions during the first caesarean section (CS), that is scalpel and diathermy, assessing differences in blood loss during incision, incisional time, total surgery time, post-operative pain, wound healing, complications, and cosmetic outcomes.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Skin incision with scalpel.
  • Procedure: Skin incision with a diathermy.
N/A

Detailed Description

The scalpel has been historically used as the primary cutting tool during caesarean section (CS). However, advancements in surgical devices have introduced alternatives, such as the option to make a diathermic cut using electrosurgical units.

General surgeons have extensively demonstrated the advantages of diathermy over the scalpel for abdominal wall incisions, including faster opening time, reduced incisional blood loss, decreased post-operative pain, and a comparable wound complication rate.

In obstetrics, there is a scarcity of evidence in this regard, and no consensus or guidelines have been established regarding the optimal method for making a transverse abdominal incision during the first elective CS. Currently, the choice between using a scalpel or diathermy remains at discretion of the obstetric surgeon. The objective of this study will be to compare both methods of skin incisions during the first CS, assessing differences in blood loss during incision, incisional time, total surgery time, post-operative pain, wound healing, complications, and cosmetic outcomes.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
84 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
Scalpel Versus Diathermy for Transverse Abdominal Incision in Women Undergoing First Elective Caesarean Section: a Randomized Controlled Trial
Anticipated Study Start Date :
Jul 1, 2023
Anticipated Primary Completion Date :
Jun 1, 2024
Anticipated Study Completion Date :
Dec 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Group_A: skin incision with scalpel.

In the scalpel group, the skin incision will be made using the traditional method, with a scalpel (No. 22).

Procedure: Skin incision with scalpel.
A Pfannenstiel skin incision will be performed using a scalpel, extending through the subcutaneous tissue and rectus sheath. After separation of rectus muscles, peritoneum will be visualized and opened. Optimal hemostasis will be achieved by applying pressure to skin blood vessels and ligating any subcutaneous bleeding. Group A: skin incision with a scalpel.

Active Comparator: Group_B: skin incision with diathermy.

In the diathermy group, the incision will be made using a small flat blade pen electrode without applying pressure. The electrode will be set to cutting mode, delivering a sinusoidal current of maximum 120 watts.

Procedure: Skin incision with a diathermy.
A Pfannenstiel skin incision will be made using a scalpel. Subsequently, a diathermy pen electrode will be employed for the dissection of deeper tissues. Optimal hemostasis will be achieved by using the same blade pen electrode, set to coagulation mode. Group B: skin incision with diathermy.

Outcome Measures

Primary Outcome Measures

  1. Incision blood loss [During surgery]

    This will be calculated by weighing the gauze pre and postoperatively (1mg = 1ml) after complete hemostasis will be achieved.

Secondary Outcome Measures

  1. Incision time [During surgery]

    We will compare incisional time by using a digital clock. The incisional time will be established as follows: when skin incision will be made, the surgeon will verbally announce "start ". Once the parietal peritoneum will be opened, the surgeon will announce "stop". The incision time will be calculated as the difference between "start" and "stop" times.

  2. Total surgery time [During surgery]

    Total surgery time will be the time between the start of the skin incision and the completion of the skin suture.

  3. Post-operative pain [During the first three days after surgery]

    Post-operative pain will be evaluated for each participant at 1, 4, 8, 16, 24, 48, 72 hours postoperatively, by using the Visual Analog Scale (VAS).

  4. Wound complications [During the first month after surgery]

    Will include edema, seroma, hematoma, dehiscence, and infection. The wound will be evaluated 24h and 72h after surgery, before patients discharge. Then, outpatient wound evaluation will be made 7 and 30 days after surgery.

  5. Cosmetic wound evaluation [One month after surgery]

    The cosmetic aspect of the wound will be evaluated outpatient 30 days after surgery by using the Patient and Observer Scar Assessment Scale (POSAS).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Women without a history of previous cesarean section or other abdominal surgery

  2. Age greater then 18 years (only adult patients)

  3. Body Mass Index (BMI) between 18.5 and 29.9 kg/m2

  4. Gestational age greater then 37 weeks (at term pregnancies)

  5. No contraindications to spinal anesthesia

  6. Indication to elective CS: extra-obstetrical reasons, failure of medical induction of labor, breech fetal presentation

  7. Informed consent

Exclusion Criteria:
  1. Women refusing to participate in the study

  2. Women undergoing urgency or emergency cesarean deliveries

  3. Women with a history of previous cesarean section or abdominal surgery

  4. Women with multifetal pregnancies

  5. Necessity of general anesthesia

  6. Use of anticoagulants

  7. Patients needing a median longitudinal abdominal section

  8. Patients with pacemakers

  9. Allergy to cephalosporins

  10. Any medical disorder that can affect wound healing as diabetes, hypertension, hepatic or renal diseases, chronic anemia, chronic skin conditions, congenital or acquired bleeding diathesis.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Azienda Ospedaliero-Universitaria "Consorziale Policlinico" Bari Italy 70124

Sponsors and Collaborators

  • Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari

Investigators

  • Principal Investigator: Amerigo Vitagliano, MD, PhD, "Aldo Moro" University of Bari

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Prof.Amerigo Vitagliano, MD, PhD, Assistant Professor (Researcher type-B), Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
ClinicalTrials.gov Identifier:
NCT05905861
Other Study ID Numbers:
  • 0049112
First Posted:
Jun 15, 2023
Last Update Posted:
Jun 15, 2023
Last Verified:
Jun 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 15, 2023